<DOC>
	<DOCNO>NCT02047981</DOCNO>
	<brief_summary>Our long-term goal precisely define role mass azithromycin treatment intervention reduce childhood mortality . We propose single multi-site ( multi-country ) , cluster-randomized trial compare community randomize oral azithromycin randomize placebo . We hypothesize mass azithromycin treatment reduce childhood mortality .</brief_summary>
	<brief_title>Mortality Reduction After Oral Azithromycin : Mortality Study</brief_title>
	<detailed_description>We assess childhood mortality two year , compare community child age 1-60 month receive biannual oral azithromycin ( `` Azithromycin '' arm ) , communities child receive biannual oral placebo ( `` Control '' arm ) . This cluster-randomized trial ; site , community within contiguous area 300,000 600,000 individual randomize azithromycin placebo use simple random sampling . Specific Aims Specific Aim 1 : To test hypothesis mass distribution oral azithromycin target 1-60 month old child reduce childhood mortality , cluster-randomized trial Specific Aim 2 : To assess cost-effectiveness mass azithromycin reduce childhood mortality</detailed_description>
	<criteria>Communities The community location target district . The community leader consent participation trial The community 's estimate population 2002,000 people . The community urban area . Individuals All child age 160 month ( include 5th birthday ) , assess via biannual census . Individuals Refusal village chief ( village inclusion ) , refusal parent guardian ( individual inclusion )</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>60 Months</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Childhood mortality</keyword>
	<keyword>Azithromycin</keyword>
	<keyword>Mass treatment</keyword>
	<keyword>Infection</keyword>
	<keyword>Verbal Autopsy</keyword>
</DOC>